News

Top 100 Pharmaceutical Enterprises and Top 10 R&D Pipeline Awards

ABOUT US

News

Top 100 Pharmaceutical Enterprises and Top 10 R&D Pipeline Awards

Release time：

2010-08-30

pharma.com/back/edit/uploadfile/2009021261.jpg">

On August 18th, the 27th Annual Meeting of National Medical and Pharmaceutical Industry Information held in

Shanghai. Meanwhile, they announced that Qilu pharma ranks 18th in “Top 100 Pharmaceutical Enterprises”, and one of “Top 10 Industry Enterprises with best R&D pipeline”, which is the only award that be accepted by China Medicine Tender. Mr. Wang Jingyi, the director of R&D Institute attends the meeting and accepts the awards

The two awards demonstrate that the industry have strong confidence in Qilu’s comprehensive competitive power and R&D capability of new product and also show Qilu’s great potentials of fast developing with the support of powerful R&D team.

Qilu Pharma exhibited on CPhI Paris 2010

Ms. Li Yan was awarded the excellent entrepreneur

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list